Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 3
2006 5
2007 3
2008 9
2009 4
2010 11
2011 23
2012 24
2013 25
2014 32
2015 40
2016 52
2017 60
2018 72
2019 72
2020 108
2021 114
2022 117
2023 111
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

837 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Lu Z, Wang J, Shu Y, Liu L, Kong L, Yang L, Wang B, Sun G, Ji Y, Cao G, Liu H, Cui T, Li N, Qiu W, Li G, Hou X, Luo H, Xue L, Zhang Y, Yue W, Liu Z, Wang X, Gao S, Pan Y, Galais MP, Zaanan A, Ma Z, Li H, Wang Y, Shen L; ORIENT-15 study group. Lu Z, et al. Among authors: luo h. BMJ. 2022 Apr 19;377:e068714. doi: 10.1136/bmj-2021-068714. BMJ. 2022. PMID: 35440464 Free PMC article. Clinical Trial.
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.
Ren S, Chen J, Xu X, Jiang T, Cheng Y, Chen G, Pan Y, Fang Y, Wang Q, Huang Y, Yao W, Wang R, Li X, Zhang W, Zhang Y, Hu S, Guo R, Shi J, Wang Z, Cao P, Wang D, Fang J, Luo H, Geng Y, Xing C, Lv D, Zhang Y, Yu J, Cang S, Yang Z, Shi W, Zou J, Zhou C; CameL-sq Study Group. Ren S, et al. Among authors: luo h. J Thorac Oncol. 2022 Apr;17(4):544-557. doi: 10.1016/j.jtho.2021.11.018. Epub 2021 Dec 16. J Thorac Oncol. 2022. PMID: 34923163 Free article. Clinical Trial.
Reply.
Cao Y, Wei J, Wang G, Chen L, Luo H, Zhou J. Cao Y, et al. Among authors: luo h. J Allergy Clin Immunol. 2020 Dec;146(6):1453-1454. doi: 10.1016/j.jaci.2020.07.037. Epub 2020 Sep 18. J Allergy Clin Immunol. 2020. PMID: 32980158 Free PMC article. No abstract available.
Preclinical models and evaluation criteria of prostatitis.
He H, Luo H, Xu H, Qian B, Zou X, Zhang G, Zeng F, Zou J. He H, et al. Among authors: luo h. Front Immunol. 2023 May 9;14:1183895. doi: 10.3389/fimmu.2023.1183895. eCollection 2023. Front Immunol. 2023. PMID: 37228599 Free PMC article. Review.
Virtual elastography ultrasound via generative adversarial network for breast cancer diagnosis.
Yao Z, Luo T, Dong Y, Jia X, Deng Y, Wu G, Zhu Y, Zhang J, Liu J, Yang L, Luo X, Li Z, Xu Y, Hu B, Huang Y, Chang C, Xu J, Luo H, Dong F, Xia X, Wu C, Hu W, Wu G, Li Q, Chen Q, Deng W, Jiang Q, Mou Y, Yan H, Xu X, Yan H, Zhou P, Shao Y, Cui L, He P, Qian L, Liu J, Shi L, Zhao Y, Xu Y, Zhan W, Wang Y, Yu J, Zhou J. Yao Z, et al. Among authors: luo h. Nat Commun. 2023 Feb 11;14(1):788. doi: 10.1038/s41467-023-36102-1. Nat Commun. 2023. PMID: 36774357 Free PMC article.
837 results